From large institutional investors to smaller quantitative investors, proxy voting guidelines increasingly reference ESG issues such as board diversity and climate change, requiring companies to meet a minimum ESG performance threshold for investors to vote in accord with management.

In this latest edition of Stern IR’s “ESG In Focus” series, we leverage proprietary data on a large number of investors in the healthcare and biotech space to assess their level of engagement around ESG and how ESG factors into their approach to proxy voting.

Read the article.